Contractile Responses to Natural Tachykinins and Selective Tachykinin Analogs in Normal and Inflamed Ileal and Colonic Muscle

References

• Barthó L, Holzer P. Search for a physiological role of substance P in gastrointestinal motility. Neuroscience 1985;16:1–32.
   Google Scholar
• Grider JR, Makhlouf GM. Regulation of the peristaltic reflex by peptides of the myenteric plexus. Arch Int Pharmacodyn Ther 1990;303:232–51.
   PubMedGoogle Scholar
• Holzer P. Implications of tachykinins and calcitonin gene-related peptide in inflammatory bowel disease. Digestion 1998; 59:269–83.
   PubMed Web of Science ®Google Scholar
• Holzer P, Holzer-Petsche U. Tachykinins in the gut. Part I. Expression, release and motor function. Pharmacol Ther 1997;73:173–217.
   PubMed Web of Science ®Google Scholar
• Tolessa T, Lördal M, Hellström PM. Contractile responses of rat duodenum caused by transmural nerve stimulation: interaction between tachykininergic and cholinergic mechanisms. Acta Physiol Scand 1996;158:135–42.
   PubMedGoogle Scholar
• Maggi CA, Patacchini R, Meini S, Quartara L, Sisto A, Potier E, et al. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon. Br J Pharmacol 1994;37:131–8.
   Google Scholar
• Holzer P, Lippe IT, Heinimann A, Barthó L. Tachykinin NK1 and NK2 receptor-mediated control of peristaltic propulsion in the guinea-pig small intestine in vitro. Neuropharmacology 1998;37: 131–8.
   Google Scholar
• Kim YC, Hellström PM. Identification of mechanisms for duodenal contraction induced by tachykinins in the rat. J Gastrointest Mot 1993;5:97–106.
   Google Scholar
• Lördal M, Theodorsson E, Hellström PM. Tachykinins influence interdigestive rhythm and contractile strength of human small intestine. Dig Dis Sci 1997;42:1940–9.
   Google Scholar
• Zagorodnyuk V, Santicioli P, Maggi CA, Giachetti A. Evidence that tachykinin NK1 and NK2 receptors mediate NANC excitation and contraction in the circular muscle of guinea-pig duodenum. Br J Pharmacol 1995;115:237–46.
   PubMed Web of Science ®Google Scholar
• Grider JR, Bitar KN, Makhlouf GM. Identification of muscarinic M2 receptors on single muscle cells of the human and guinea pig intestine. Gastroenterology 1987;93: 951–7.
   Google Scholar
• Holzer P, Holzer-Petsche U. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol Ther 1997;73:219–63.
   Google Scholar
• Tateishi K, Kishimoto S, Kobayashi H, Kobuke K, Matsuoka Y. Distribution and localization of neurokinin A-like immuno-reactivity and neurokinin B-like immunoreactivity in rat peripheral tissue. Regul Pept 1990;30:193–200.
   Google Scholar
• Ekblad E, Winther C, Ekman R, H^kanson R, Sundler F. Projections of peptide-containing neurons in rat small intestine. Neuroscience 1987;20:69–188.
   Google Scholar
• Theodorsson-Norheim E, Brodin E, Norheim I, Rosell S. Antisera raised against eledoisin and kassinin detect immuno-reactive material in rat tissue extracts: tissue distribution and chromatographic characterization. Regul Pept 1984;9:229–44.
   Google Scholar
• Schultzberg M, Hökfelt T, Nilsson G, Terenius L, Rehfeld JF, Brown M, et al. Distribution of peptide and catecholamine-containing neurons in the gastrointestinal tract of rat and guineapig: immunohistochemical studies with antisera to substance P, vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin, and dopamin β-hydroxylase. Neuroscience 1980;5:689–744.
   PubMed Web of Science ®Google Scholar
• Kunze WA, Furness JB. The enteric nervous system and regulation of intestinal motility. Annu Rev Physiol 1999;6:117–42.
   Web of Science ®Google Scholar
• Regoli D, Nguyen K, Calo G. Neurokinin receptors. Comparison of data from classical pharmacology, binding, and molecular biology. Ann NY Acad Sci 1997;812:144–6.
   Google Scholar
• Hellström PM, Murthy KS, Grider JR, Makhlouf GM. Coexistence of three tachykinin receptors coupled to Ca⁺⁺ signaling pathways in intestinal muscle cells. J Pharm Exp Ther 1994; 270:236–43.
   Google Scholar
• Lördal M, Johansson C, Hellström PM. Myoelectric pattern and effects on small bowel transit induced by the tachykinins neurokinin A, neurokinin B, substance P and neuropeptide K in the rat. J Gastrointest Mot 1993;5:33–40.
   Google Scholar
• Rahman M, Lördal M, Al-Saffar A, Hellström PM. Intestinal motility responses to neuropeptide γ in vitro and in vivo in the rat: comparison with neurokinin 1 and neurokinin 2 receptor agonists. Acta Physiol Scand 1994;151:497–505.
   PubMedGoogle Scholar
• Kage R, McGregor GP, Thim L, Conlon JM. Neuropeptide γ: a peptide isolated from rabbit that is derived from a γ-preprotachykinin. J Neurochem 1988;50:1412–7.
   PubMed Web of Science ®Google Scholar
• Maggi CA, Patacchini R, Giachetti A, Meli A. Human isolated ileum: motor responses of the circular muscle to electrical field stimulation and exogenous neuropeptides. Naunyn Schmiedebergs Arch Pharmacol 1990;341:256–61.
   PubMed Web of Science ®Google Scholar
• Maggi CA, Patacchini R, Santicioli P, Giuliani S, Turini D, Barbanti G, et al. Human isolated small intestine: motor responses of the longitudinal muscle to field stimulation and exogenous neuropeptides. Naunyn Schmiedebergs Arch Pharmacol 1989;339:415–23.
   PubMed Web of Science ®Google Scholar
• Maggi CA, Catalioto RM, Criscuoli M, Cucchi P, Giuliani S, Lecci A, et al. Tachykinin receptors and intestinal motility. Can J Physiol Pharmacol 1997;75:696–703.
   PubMed Web of Science ®Google Scholar
• Maggi CA, Giuliani S, Patacchini R, Santicioli P, Theodorsson E, Barbanti G, et al. Tachykinin antagonists inhibit nervemediated contractions in the circular muscle of the human ileum. Involvement of neurokinin-2 receptors. Gastroenterology 1992;102:88–96.
   PubMed Web of Science ®Google Scholar
• Patacchini R, Astolfi M, Brown MC, Maggi CA. Actinomycin D is a competitive and selective antagonist at NK2 tachykinin receptors. Neuropeptides 1991;20:109–14.
   PubMed Web of Science ®Google Scholar
• Di Sebastiano P, Grossi L, Di Mola FF, Angelucci D, Friess H, Marzio L, et al. SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis. Dig Dis Sci 1999;44:439–44.
   PubMed Web of Science ®Google Scholar
• Martinsson T, Ljung T, Dalsgaard C-J, Hellström PM. Beneficial effects of ropivacaine in experimental colitis: accelerated mucosal healing and restored motor activity. J Pharm Exp Ther 1999;291:642–7.
   Google Scholar
• Mourelle M, Casellas F, Guarner F, Salas A, Riveros-Moreno V, Moncada S, et al. Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterology 1995;109:1497–502.
   Google Scholar
• Bishop AE, Polak JM, Bryant MG, Bloom SR, Hamilton S. Abnormalities of vasoactive intestinal polypeptide containing nerves in Crohn’s disease. Gastroenterology 1980;79:853–60.
   Google Scholar
• Koch TR, Carney JA, Go VLW. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci 1987;32:369–76.
   Google Scholar
• Duffy LC, Zielezny MA, Riepenhoff-Talty M, Byers TE, Marshall J, Weiser MM, et al. Vasoactive intestinal peptide as a laboratory supplement to clinical activity index in inflammatory bowel disease. Dig Dis Sci 1989;34:1528–35.
   Google Scholar
• Surrenti C, Renzi D, Garcea MR, Surrenti E, Salvadori G. Colonic vasoactive intestinal polypeptide in ulcerative colitis. J Physiol Paris 1993;87:307–11.
   Google Scholar
• Kimura M, Masuda T, Hiwatashi N, Toyota T, Nagura H. Changes in neuropeptide-containing nerves in human colonic mucosa with inflammatory bowel disease. Pathol Int 1994;44: 624–34.
   Google Scholar
• Koch TR, Go L, Carney A, Go W. Colonic vasoactive intestinal peptide-containing nerves in Crohn’s disease and ulcerative colitis. Ann NY Acad Sci 1988;527:646–9.
   Google Scholar
• Koch TR, Roddy DR, Carney JA, Go VLW. Peptide YY concentrations in normal ileum and colon and in idiopathic inflammatory bowel disease. Dig Dis Sci 1988;33:1322–8.
   PubMed Web of Science ®Google Scholar
• Koch TR, Carney JA, Morris VA, Go VLW. Somatostatin in the idiopathic inflammatory bowel diseases. Dis Colon Rectum 1988;31:198–203.
   PubMed Web of Science ®Google Scholar
• Bernstein CN, Robert ME, Eysselein VE. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn’s disease. Am J Gastroenterol 1993;88:908–13.
   Google Scholar
• Renzi D, Mantellini P, Calabro A, Panerai C, Amorosi A, Paladini I, et al. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis. Ital J Gastroenterol 1998;30:62–70.
   Google Scholar
• Watanabe T, Kubota Y, Muto T. Substance P containing nerve fibers in rectal mucosa of ulcerative colitis. Dis Colon Rectum 1997;40:718–25.
   Google Scholar
• Keranen U, Kiviluoto T, Jarvinen H, Back N, Kivilaakso E, Soinila S. Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis. Dig Dis Sci 1995;40:2250–8.
   PubMed Web of Science ®Google Scholar
• Hellström PM, Al-Saffar A, Ljung T, Theodorsson E. Endotoxin actions on myoelectric activity, transit, and neuropeptides in the gut. Role of nitric oxide. Dig Dis Sci 1997;42:1640–51.
   PubMed Web of Science ®Google Scholar
• Eysselein VE, Reinshagen M, Cominelli F, Sternini C, Davis W, Patel A, et al. Calcitonin gene-related peptide and substance P decrease in rabbit colon during colitis. Gastroenterology 1991;101:1211–9.
   PubMed Web of Science ®Google Scholar
• Mantyh CR, Vigna SR, Maggio JE, Mantyh PW, Bollinger RR, Pappas TN. Substance P binding sites on intestinal lymphoid aggregates and blood vessels in inflammatory bowel disease correspond to authentic NK-1 receptors. Neurosci Lett 1994; 178:255–9.
   PubMed Web of Science ®Google Scholar